cancer.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Acute lymphoblastic leukemia Age 6 to 12 years First course of chemotherapy No speech, vision, or hearing disorders, or mental retardation No neurological deficits affecting pain perception based on medical records In stage one (Induction Phase) or stage two (Consolidation Phase) of cancer Under treatment with L-asparaginase Willingness to participate in the study Non-dominant arm line is fixed.
Exclusion criteria
Exclusion criteria: Reluctance to continue the study process Development of poisoning from chemotherapy drugs Occurrence of emergency situations such as cardiopulmonary resuscitation or seizure, etc Not playing games or watching with virtual reality glasses for more than 10 minutes
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Before starting chemotherapy, during chemotherapy, and after completing chemotherapy. Method of measurement: Oucher Pain Scale.;Fear. Timepoint: Before starting chemotherapy, during chemotherapy, and after completing chemotherapy. Method of measurement: Children's Fear Scale.;Anxiety. Timepoint: Before starting chemotherapy, during chemotherapy, and after completing chemotherapy. Method of measurement: Visual-Facial-Anxiety-Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Hamedan University of Medical Sciences